Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Viscoli

Showing results (121-130 of 171) with videos related to

Pageof 18
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2016
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infectionsA Russo, E Concia, F Cristini, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2019
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapyE Furfaro, A Signori, C Di Grazia, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethicalC Orasch, D Averbuch, M Mikulska, et al.
Epidemiology and Infection|January 14, 2011
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortalityM Tumbarello, E Repetto, E M Trecarichi, et al.
AIDS Care|February 3, 2017
Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. study-investigation on antiretroviral therapy)A Venturini, G Cenderello, A Di Biagio, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 1, 2014
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcomeM Mikulska, L Nicolini, A Signori, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 20, 2010
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipientsM Mikulska, V Del Bono, R Prinapori, et al.
The Journal of Antimicrobial Chemotherapy|January 5, 2008
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infectionsM Bassetti, E Repetto, E Righi, et al.
HIV Medicine|May 31, 2018
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparisonL Taramasso, A Di Biagio, F Maggiolo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 18, 2011
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemiaM Bassetti, E M Trecarichi, A Mesini, et al.
Pageof 18

Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 30, 2016
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infectionsA Russo, E Concia, F Cristini, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2019
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapyE Furfaro, A Signori, C Di Grazia, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 7, 2015
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethicalC Orasch, D Averbuch, M Mikulska, et al.
Epidemiology and Infection|January 14, 2011
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortalityM Tumbarello, E Repetto, E M Trecarichi, et al.
AIDS Care|February 3, 2017
Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. study-investigation on antiretroviral therapy)A Venturini, G Cenderello, A Di Biagio, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 1, 2014
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcomeM Mikulska, L Nicolini, A Signori, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 20, 2010
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipientsM Mikulska, V Del Bono, R Prinapori, et al.
The Journal of Antimicrobial Chemotherapy|January 5, 2008
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infectionsM Bassetti, E Repetto, E Righi, et al.
HIV Medicine|May 31, 2018
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparisonL Taramasso, A Di Biagio, F Maggiolo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 18, 2011
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemiaM Bassetti, E M Trecarichi, A Mesini, et al.
Pageof 18